Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities

被引：11

作者：

Song, Joo Y. ^{[1
]}

Dirnhofer, Stefan ^{[2
]}

Piris, Miguel A. ^{[3
]}

Quintanilla-Martinez, Leticia ^{[4
,5
,6
]}

Pileri, Stefano ^{[7
]}

Campo, Elias ^{[8
]}

机构：

[1] City Hope Natl Med Ctr, Dept Pathol, 1500 E Duarte Rd, Duarte, CA 91010 USA

[2] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland

[3] Fdn Jimenez Diaz, Serv Anat Patol, CIBERONC, Madrid, Spain

[4] Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany

[5] Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany

[6] Image Guided & Funct Instructed Tumor Therapy, Cluster Excellence iFIT, Tubingen, Germany

[7] European Inst Oncol IRCCS, Div Hematopathol, Milan, Italy

[8] Univ Barcelona, Hosp Clin Barcelona, Inst Biomed Res August Pi I Sunyer IDIBAPS, Hematopathol Unit, Barcelona, Spain

来源：

VIRCHOWS ARCHIV | 2022年 / 482卷 / 1期

关键词：

Diffuse large B-cell lymphoma; Update; Classification; Molecular; Genomics; CENTRAL-NERVOUS-SYSTEM; PREVIOUSLY UNTREATED PATIENTS; EFFUSION-BASED LYMPHOMA; EXPRESSION PREDICTS; CD79B MUTATIONS; GENE-EXPRESSION; MYD88; L265P; R-CHOP; CLASSIFICATION; MYC;

D O I：

10.1007/s00428-022-03466-6

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogenous group of diseases and the most common subtype of non-Hodgkin lymphoma. In the past decade, there has been an explosion in molecular profiling that has helped to identify subgroups and shared oncogenic driving mechanisms. Since the 2017 World Health Organization (WHO) classification, additional studies investigating these genomic abnormalities and phenotypic findings have been reported. Here we review these findings in DLBCL and address the proposed changes by the 2022 International Consensus Classification.

引用

页码：179 / 192

页数：14

共 50 条

[31] Diffuse large B-cell lymphoma, not otherwise specified presenting with bone and bone marrow involvement in the absence of lymphadenopathy
Hisaharu Shikata
Masaki Maruta
Masahiko Kaneko
International Cancer Conference Journal, 2016, 5 (4) : 183 - 186
[32] Genetic lesions in diffuse large B-cell lymphomas
Testoni, M.
Zucca, E.
Young, K. H.
Bertoni, F.
ANNALS OF ONCOLOGY, 2015, 26 (06) : 1069 - 1080
[33] Logical analysis of diffuse large B-cell lymphomas
Alexe, G
Alexe, S
Axelrod, DE
Hammer, PL
Weissmann, D
ARTIFICIAL INTELLIGENCE IN MEDICINE, 2005, 34 (03) : 235 - 267
[34] Diffuse large B-cell lymphoma, not otherwise specified presenting with bone and bone marrow involvement in the absence of lymphadenopathy
Shikata, Hisaharu
Maruta, Masaki
Kaneko, Masahiko
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (04): : 183 - 186
[35] Phenotype profiling of primary testicular diffuse large B-cell lymphomas
Menter, Thomas
Ernst, Martina
Drachneris, Julius
Dirnhofer, Stephan
Barghorn, Andre
Went, Philip
Tzankov, Alexandar
HEMATOLOGICAL ONCOLOGY, 2014, 32 (02) : 72 - 81
[36] Diffuse large B-cell lymphoma
Barraclough, Allison
Hawkes, Eliza
Sehn, Laurie H.
Smith, Sonali M.
HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
[37] EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management
Beltran, Brady E.
Castro, Denisse
Paredes, Sally
Miranda, Roberto N.
Castillo, Jorge J.
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (04) : 435 - 445
[38] Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Merli, Michele
Frigeni, Marco
Alric, Laurent
Visco, Carlo
Besson, Caroline
Mannelli, Lara
Di Rocco, Alice
Ferrari, Angela
Farina, Lucia
Pirisi, Mario
Piazza, Francesco
Loustaud-Ratti, Veronique
Arcari, Annalisa
Marino, Dario
Sica, Antonello
Goldaniga, Maria
Rusconi, Chiara
Gentile, Massimo
Cencini, Emanuele
Benanti, Francesco
Rumi, Maria Grazia
Ferrrtti, Virginia Valeria
Grossi, Paolo
Gotti, Manuel
Sciarra, Roberta
Tisi, Maria Chiara
Cano, Isabel
Zuccaro, Valentina
Passamonti, Francesco
Arcaini, Luca
ONCOLOGIST, 2019, 24 (08) : E720 - E729
[39] Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specified
Itami, Hiroe
Nakamine, Hirokazu
Kubo, Masayuki
Ogawa, Kohei
Tani, Rina
Nakamura, Shinji
Takeda, Maiko
Nitta, Yuji
Uchiyama, Tomoko
Fujii, Tomomi
Hatakeyama, Kinta
Ohbayashi, Chiho
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (03) : 152 - 161
[40] Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities
De Paepe, P.
De Wolf-Peeters, C.
LEUKEMIA, 2007, 21 (01) : 37 - 43

← 1 2 3 4 5 →